Shoulder Innovations (NYSE:SI) CFO Jeffrey Points Acquires 995 Shares of Stock

Shoulder Innovations, Inc. (NYSE:SI) CFO Jeffrey Points purchased 995 shares of Shoulder Innovations stock in a transaction that occurred on Thursday, December 11th. The shares were bought at an average price of $14.65 per share, for a total transaction of $14,576.75. Following the completion of the transaction, the chief financial officer owned 53,440 shares in the company, valued at $782,896. The trade was a 1.90% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Shoulder Innovations Stock Up 0.8%

Shares of SI stock opened at $14.49 on Tuesday. Shoulder Innovations, Inc. has a fifty-two week low of $10.92 and a fifty-two week high of $17.94. The company has a 50 day moving average of $13.45.

Shoulder Innovations (NYSE:SI) last issued its earnings results on Tuesday, November 11th. The company reported ($0.48) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.37) by ($0.11). The firm had revenue of $11.76 million for the quarter, compared to analysts’ expectations of $9.99 million. On average, equities analysts predict that Shoulder Innovations, Inc. will post -0.56 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Jefferies Financial Group started coverage on shares of Shoulder Innovations in a research report on Monday, August 25th. They issued a “buy” rating and a $19.00 price objective on the stock. Weiss Ratings restated a “sell (e)” rating on shares of Shoulder Innovations in a report on Monday, December 8th. Morgan Stanley increased their price objective on Shoulder Innovations from $18.00 to $23.00 and gave the stock an “overweight” rating in a report on Tuesday, December 2nd. Wall Street Zen upgraded Shoulder Innovations from a “sell” rating to a “hold” rating in a research report on Saturday, October 11th. Finally, Zacks Research upgraded Shoulder Innovations to a “hold” rating in a report on Tuesday, August 26th. Five equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $20.60.

Institutional Trading of Shoulder Innovations

Several institutional investors and hedge funds have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Shoulder Innovations during the 3rd quarter valued at approximately $28,000. Rhumbline Advisers purchased a new position in shares of Shoulder Innovations in the 3rd quarter valued at approximately $54,000. Board of Trustees of The Leland Stanford Junior University bought a new stake in shares of Shoulder Innovations during the third quarter valued at approximately $170,000. Bank of America Corp DE purchased a new stake in Shoulder Innovations in the third quarter worth $322,000. Finally, Monashee Investment Management LLC bought a new position in Shoulder Innovations in the third quarter worth $502,000.

About Shoulder Innovations

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.